US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

YD Bio Ltd

3.93

-0.3250-7.65%

Volume:730.53K

Turnover:2.93M

Market Cap:276.80M

PE:-33.55

High:4.38

Open:4.36

Low:3.65

Close:4.25

52wk High:25.00

52wk Low:1.70

Shares:70.52M

Float Shares:16.23M

Volume Ratio:1.28

T/O Rate:4.50%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.1170

EPS(LYR):-1.2901

ROE:-42.69%

ROA:-25.43%

PB:42.00

PE(LYR):-3.04

Loading ...

Overview Company News Filings

YD Bio CEO Ethan Shen Acquires 18,378 Shares Valued at $67,246.26

YD Bio Management Commentary Cites Larger Drug, Medical Product Orders Driving H1 2026 Revenue up to $0.8 Million

YD Bio 1H FY26 Net Income Swings to USD 6.7 Million; Revenue Rises 315% to USD 846,501

Yd Bio Limited Reports Unaudited Financial Results for the Six Months Ended June 30, 2026

THOMSON REUTERS

Press Release: YD Bio Limited Reports Unaudited Financial Results for the Six Months Ended June 30, 2026

NASDAQ Trade Halt Volatility Trading Pause at 11:28 Am

NASDAQ Trade Halt Volatility Trading Pause at 03:43 Pm

YD Bio Reports Peer-Reviewed Nutrients Publication on Omega-3, Vitamins D3 and K2 "heart-Brain-Bone" Axis

Yd Bio Launches a Physician-Partnership Initiative in Taiwan with the Announcement of Two Nutraceutical Products in Collaboration with the Taiwan Chronic Disease Healthcare Association and the Future Health Institute

THOMSON REUTERS

YD Bio Highlights Peer-Reviewed Computational Study Nominating Keratoconus Regenerative Therapy Targets

YD Bio Launches Cancer Testing Pilot with Numia Health in Canada

YD Bio Wins Rhode Island, Pennsylvania Lab Licenses, Expanding U.S. Footprint to 46 States

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:48 PM

Yd Bio Limited Reports Full Year 2025 Financial Results

THOMSON REUTERS

YD Bio FY25 net loss widens to $8.3 million; revenue rises 17% to $596,817

YD Bio Ltd trading halted, volatility trading pause

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:56 PM

YD Bio files Form 3 as director Kochi Chang reports no beneficial ownership

YD Bio files Form 3; director Jerry Yin-Chia Lee reports no securities owned

YD Bio files initial beneficial ownership statement; Chief Medical Officer and director Zhang Bo-Xiang reports 31,141 ordinary shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/YDES/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"YDES","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"YDES\",,,,,undefined,":{"symbol":"YDES","market":"US","secType":"STK","nameCN":"YD Bio Ltd","latestPrice":3.925,"timestamp":1788984000000,"preClose":4.25,"halted":0,"volume":730532,"delay":0,"changeRate":-0.07647058823529417,"floatShares":16227800,"shares":70521359,"eps":-0.117,"marketStatus":"Pre-Mkt","change":-0.325,"latestTime":"09-10 07:11:01 EDT","open":4.36,"high":4.38,"low":3.65,"amount":2926237.7538724,"amplitude":0.171765,"askPrice":4.66,"askSize":100,"bidPrice":3.78,"bidSize":251,"shortable":0,"etf":0,"ttmEps":-0.117,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789047000000},"marketStatusCode":1,"adr":0,"listingDate":1756440000000,"exchange":"NASDAQ","adjPreClose":3.925,"postHourTrading":{"tag":"盘后","latestPrice":3.87,"preClose":3.925,"latestTime":"19:48 EDT","volume":2364,"amount":9174.1245,"timestamp":1788997705773,"change":-0.055,"changeRate":-0.014013,"amplitude":0.014013},"volumeRatio":1.2778693082096408},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"YDES\",,,,,undefined,":{"symbol":"YDES","floatShares":16227800,"roa":"-25.43%","roe":"-42.69%","lyrEps":-1.290101,"volumeRatio":1.2778693082096408,"shares":70521359,"dividePrice":0,"high":4.38,"amplitude":0.171765,"preClose":4.25,"low":3.65,"week52Low":1.7,"pbRate":"42.00","psRate":"542.36","week52High":25,"institutionHeld":0,"latestPrice":3.925,"committee":0.430199,"eps":-0.117,"divideRate":0,"volume":730532,"delay":0,"ttmEps":-0.117,"open":4.36,"prevYearClose":12.19,"prevWeekClose":3.54,"prevMonthClose":3.71,"prevQuarterClose":2.25,"fiveDayClose":3.775,"twentyDayClose":2.73,"sixtyDayClose":3.27},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/YDES\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-31","symbol":"YDES","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1788148800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2026-04-30","symbol":"YDES","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1777521600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-08-19","symbol":"YDES","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755576000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"YDES\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"YDES\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/YDES\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"YDES","date":"2026-09-09","current":-33.547009,"percent":0.743902,"low":-1151.273969,"twenty":-617.533194,"median":-389.071817,"eighty":-162.104954,"high":-94.652554,"avg":-425.23115,"sd":259.104166,"marketCap":298859252},"quantilePoints":[{"date":"2025-09-19","current":-961.968859,"twenty":-999.829881,"median":-916.635267,"eighty":-851.374822,"marketCap":1357875801},{"date":"2025-09-26","current":-709.645075,"twenty":-998.136098,"median":-925.353266,"eighty":-851.374822,"marketCap":1001705892},{"date":"2025-10-03","current":-960.225259,"twenty":-973.028263,"median":-916.635267,"eighty":-851.374822,"marketCap":1355414607},{"date":"2025-10-10","current":-932.078579,"twenty":-963.563007,"median":-911.653554,"eighty":-851.474456,"marketCap":1315683907},{"date":"2025-10-17","current":-939.800234,"twenty":-960.573979,"median":-919.624296,"eighty":-852.27153,"marketCap":1326583479},{"date":"2025-10-24","current":-877.279731,"twenty":-963.563007,"median":-920.745181,"eighty":-864.327276,"marketCap":1238332100},{"date":"2025-10-31","current":-553.468359,"twenty":-960.573979,"median":-906.67184,"eighty":-851.474456,"marketCap":781253244},{"date":"2025-11-07","current":-468.779231,"twenty":-944.084508,"median":-894.715728,"eighty":-771.61759,"marketCap":661709543},{"date":"2025-11-14","current":-504.149397,"twenty":-939.850051,"median":-872.298018,"eighty":-562.236175,"marketCap":711636618},{"date":"2025-11-21","current":-416.471241,"twenty":-935.217058,"median":-854.36385,"eighty":-532.644798,"marketCap":587873728},{"date":"2025-11-28","current":-574.391556,"twenty":-932.875653,"median":-852.122079,"eighty":-497.174998,"marketCap":810787570},{"date":"2025-12-05","current":-636.164802,"twenty":-928.790648,"median":-849.382136,"eighty":-516.703315,"marketCap":897984152},{"date":"2025-12-12","current":-626.201375,"twenty":-924.506374,"median":-777.645464,"eighty":-530.751747,"marketCap":883920187},{"date":"2025-12-19","current":-564.677215,"twenty":-922.364238,"median":-692.707249,"eighty":-539.021391,"marketCap":797075205},{"date":"2025-12-26","current":-621.717833,"twenty":-920.969359,"median":-645.630058,"eighty":-546.593595,"marketCap":877591403},{"date":"2026-01-02","current":-607.270864,"twenty":-919.02649,"median":-636.164802,"eighty":-555.660313,"marketCap":857198654},{"date":"2026-01-09","current":-614.245263,"twenty":-914.642582,"median":-629.688575,"eighty":-564.477946,"marketCap":867043429},{"date":"2026-01-16","current":-568.911671,"twenty":-905.326777,"median":-626.699546,"eighty":-565.524106,"marketCap":803052390},{"date":"2026-01-23","current":-612.750749,"twenty":-899.946527,"median":-622.714176,"eighty":-564.677215,"marketCap":864933835},{"date":"2026-01-30","current":-549.482989,"twenty":-896.708414,"median":-621.717833,"eighty":-564.677215,"marketCap":775627658},{"date":"2026-02-06","current":-536.032363,"twenty":-892.723043,"median":-616.73612,"eighty":-563.929958,"marketCap":756641306},{"date":"2026-02-13","current":-488.706085,"twenty":-877.279731,"median":-614.494349,"eighty":-554.464703,"marketCap":689837473},{"date":"2026-02-20","current":-438.39078,"twenty":-873.294361,"median":-611.928766,"eighty":-547.988475,"marketCap":618814451},{"date":"2026-02-27","current":-449.84872,"twenty":-868.312647,"median":-609.761721,"eighty":-532.644798,"marketCap":634988010},{"date":"2026-03-06","current":-417.392858,"twenty":-858.548489,"median":-606.523607,"eighty":-488.307548,"marketCap":589174645},{"date":"2026-03-13","current":-374.126677,"twenty":-853.168238,"median":-599.051037,"eighty":-460.210684,"marketCap":528101878},{"date":"2026-03-20","current":-270.008867,"twenty":-852.371164,"median":-597.058352,"eighty":-440.283831,"marketCap":381133446},{"date":"2026-03-27","current":-385.086446,"twenty":-851.972627,"median":-591.329381,"eighty":-432.31309,"marketCap":543572239},{"date":"2026-04-02","current":-363.166907,"twenty":-850.677382,"median":-588.838525,"eighty":-423.505421,"marketCap":512631516},{"date":"2026-04-10","current":-287.943035,"twenty":-849.581405,"median":-577.62967,"eighty":-418.782756,"marketCap":406448582},{"date":"2026-04-17","current":-264.030811,"twenty":-817.997342,"median":-572.897042,"eighty":-404.415494,"marketCap":372695067},{"date":"2026-04-24","current":-261.290868,"twenty":-791.09609,"median":-569.160757,"eighty":-391.761942,"marketCap":368827476},{"date":"2026-05-01","current":-254.067384,"twenty":-775.752412,"median":-564.428129,"eighty":-384.588275,"marketCap":358631102},{"date":"2026-05-08","current":-263.607365,"twenty":-733.059128,"median":-562.933615,"eighty":-378.610219,"marketCap":372097348},{"date":"2026-05-15","current":-252.074698,"twenty":-699.482379,"median":-554.464703,"eighty":-359.839123,"marketCap":355818309},{"date":"2026-05-22","current":-225.173446,"twenty":-672.830213,"median":-549.98116,"eighty":-320.324172,"marketCap":317845604},{"date":"2026-05-29","current":-174.858141,"twenty":-653.999336,"median":-541.263162,"eighty":-287.345229,"marketCap":246822582},{"date":"2026-06-05","current":-156.674886,"twenty":-645.630058,"median":-534.537849,"eighty":-272.001552,"marketCap":221155846},{"date":"2026-06-12","current":-161.905686,"twenty":-641.843956,"median":-497.174998,"eighty":-270.30777,"marketCap":228539428},{"date":"2026-06-18","current":-125.539178,"twenty":-635.268094,"median":-487.709742,"eighty":-264.528982,"marketCap":177205956},{"date":"2026-06-26","current":-120.557464,"twenty":-631.282723,"median":-463.299347,"eighty":-261.754167,"marketCap":170173974},{"date":"2026-07-02","current":-115.077579,"twenty":-629.688575,"median":-449.84872,"eighty":-258.745212,"marketCap":162438793},{"date":"2026-07-10","current":-106.608667,"twenty":-629.688575,"median":-440.383465,"eighty":-257.056411,"marketCap":150484423},{"date":"2026-07-17","current":-122.55015,"twenty":-628.692232,"median":-438.39078,"eighty":-252.074698,"marketCap":172986767},{"date":"2026-07-24","current":-101.626953,"twenty":-626.699546,"median":-432.163639,"eighty":-236.631387,"marketCap":143452440},{"date":"2026-07-31","current":-109.597694,"twenty":-626.301009,"median":-425.986313,"eighty":-211.02538,"marketCap":154703612},{"date":"2026-08-07","current":-117.772686,"twenty":-623.411616,"median":-420.954783,"eighty":-167.688458,"marketCap":166243095},{"date":"2026-08-14","current":-125.041006,"twenty":-622.315638,"median":-418.551107,"eighty":-158.468303,"marketCap":176502758},{"date":"2026-08-21","current":-238.41484,"twenty":-621.817467,"median":-406.004661,"eighty":-158.468303,"marketCap":336536613},{"date":"2026-08-28","current":-192.792308,"twenty":-621.717833,"median":-402.522444,"eighty":-160.112269,"marketCap":272137718},{"date":"2026-09-04","current":-182.828882,"twenty":-618.529536,"median":-393.555359,"eighty":-161.606783,"marketCap":258073754},{"date":"2026-09-09","current":-211.72282,"twenty":-617.533194,"median":-389.071817,"eighty":-162.104954,"marketCap":298859252}],"updateTime":1789038662297},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"YDES\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666537222","title":"YD Bio CEO Ethan Shen Acquires 18,378 Shares Valued at $67,246.26","url":"https://stock-news.laohu8.com/highlight/detail?id=2666537222","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666537222?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:00","pubTimestamp":1788897657,"startTime":"0","endTime":"0","summary":"YD Bio CEO Ethan Shen acquires 18,378 shares valued at $67,246.26YD Bio: CEO and director Ethan Shen PhD reported a purchase of 18,378 ordinary shares at a weighted average price of USD 3.67.Directly ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL3y053W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"YD Bio CEO Ethan Shen Acquires 18,378 Shares Valued at $67,246.26","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YDES","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664830777","title":"YD Bio Management Commentary Cites Larger Drug, Medical Product Orders Driving H1 2026 Revenue up to $0.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2664830777","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664830777?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:05","pubTimestamp":1788257116,"startTime":"0","endTime":"0","summary":"YD Bio management commentary cites larger drug, medical product orders driving H1 2026 revenue up to $0.8 millionIn management commentary for the six months ended June 30, 2026, net revenue rose to $8","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL8kh2f1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","YDES"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664859148","title":"YD Bio 1H FY26 Net Income Swings to USD 6.7 Million; Revenue Rises 315% to USD 846,501","url":"https://stock-news.laohu8.com/highlight/detail?id=2664859148","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664859148?lang=en_us&edition=fundamental","pubTime":"2026-09-01 06:00","pubTimestamp":1788213639,"startTime":"0","endTime":"0","summary":"YD Bio 1H FY26 net income swings to USD 6.7 million; revenue rises 315% to USD 846,501YD Bio posted net income of US$6.7 million as revenue climbed 315% to US$846,501 in the six months ended June 30, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL4lsg82:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","IE00B3QW5Z07.USD","IE00BQXX3C00.GBP","BCDF","SG9999014021.USD","BK4588","LU2095319765.USD","YDES","SG9999014013.SGD","IE00BKPKM429.USD","BK4585","IE00BQXX3F31.USD","LU0314104364.USD","SG9999014039.USD","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","IE00BN0W2W23.USD","LU2210150020.SGD","IE00BN0W2T93.GBP","IE00BQXX3D17.EUR","IE00B64PRP62.GBP","LU2210149790.SGD","BK4139","SG9999014005.SGD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664859188","title":"Yd Bio Limited Reports Unaudited Financial Results for the Six Months Ended June 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2664859188","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664859188?lang=en_us&edition=fundamental","pubTime":"2026-09-01 06:00","pubTimestamp":1788213600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUA23C6ZV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["YDES","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664885972","title":"Press Release: YD Bio Limited Reports Unaudited Financial Results for the Six Months Ended June 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2664885972","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664885972?lang=en_us&edition=fundamental","pubTime":"2026-09-01 06:00","pubTimestamp":1788213600,"startTime":"0","endTime":"0","summary":"TAIPEI, Taiwan, Aug. 31, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (\"YD Bio\" or the \"Company\") (Nasdaq: YDES), a biotechnology company advancing DNA methylation--based cancer detection technology and op","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YDES","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663004280","title":"NASDAQ Trade Halt Volatility Trading Pause at 11:28 Am","url":"https://stock-news.laohu8.com/highlight/detail?id=2663004280","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663004280?lang=en_us&edition=fundamental","pubTime":"2026-08-31 23:28","pubTimestamp":1788190117,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTVOLATILITY TRADING PAUSE AT 11:28 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nAQN2MHF22:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","YDES"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663135590","title":"NASDAQ Trade Halt Volatility Trading Pause at 03:43 Pm","url":"https://stock-news.laohu8.com/highlight/detail?id=2663135590","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663135590?lang=en_us&edition=fundamental","pubTime":"2026-08-29 03:43","pubTimestamp":1787946222,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTVOLATILITY TRADING PAUSE AT 03:43 PM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nAQN2MH0R0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YDES","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662343837","title":"YD Bio Reports Peer-Reviewed Nutrients Publication on Omega-3, Vitamins D3 and K2 \"heart-Brain-Bone\" Axis","url":"https://stock-news.laohu8.com/highlight/detail?id=2662343837","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662343837?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:02","pubTimestamp":1787659325,"startTime":"0","endTime":"0","summary":"YD Bio reports peer-reviewed Nutrients publication on omega-3, vitamins D3 and K2 \"heart-brain-bone\" axisYD Bio announced a peer-reviewed review article published in MDPI’s Nutrients on Aug. 19, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nNDL339n93:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","IE00BN0W2W23.USD","IE00BKPKM429.USD","LU2210149790.SGD","BK4588","LU2095319765.USD","BK4112","SG9999014021.USD","YDES","SG9999014013.SGD","LU2210150020.SGD","LU0314104364.USD","IE00B3QW5Z07.USD","IE00BQXX3C00.GBP","IE00B64PRP62.GBP","IE00BQXX3F31.USD","SG9999014005.SGD","SG9999014039.USD","BCDF","NDAQ","BK4139","BK4585","IE00BN0W2T93.GBP","IE00BGHQF748.EUR","IE00BQXX3D17.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658997056","title":"Yd Bio Launches a Physician-Partnership Initiative in Taiwan with the Announcement of Two Nutraceutical Products in Collaboration with the Taiwan Chronic Disease Healthcare Association and the Future Health Institute","url":"https://stock-news.laohu8.com/highlight/detail?id=2658997056","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658997056?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:00","pubTimestamp":1786449605,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nTUA3WPFCM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["YDES","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656455599","title":"YD Bio Highlights Peer-Reviewed Computational Study Nominating Keratoconus Regenerative Therapy Targets","url":"https://stock-news.laohu8.com/highlight/detail?id=2656455599","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656455599?lang=en_us&edition=fundamental","pubTime":"2026-08-04 20:07","pubTimestamp":1785845249,"startTime":"0","endTime":"0","summary":"YD Bio highlights peer-reviewed computational study nominating keratoconus regenerative therapy targetsYD Bio highlighted a new peer-reviewed computational study on keratoconus in Bioengineering; no c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL5mXG3r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","LU2210149790.SGD","LU2095319765.USD","BK4139","IE00B3QW5Z07.USD","LU0314104364.USD","IE00B64PRP62.GBP","LU2210150020.SGD","SG9999014005.SGD","SG9999014039.USD","IE00BN0W2W23.USD","IE00BGHQF748.EUR","BK4585","YDES","IE00BKPKM429.USD","SG9999014013.SGD","BK4588","IE00BN0W2T93.GBP","BK4112","SG9999014021.USD","BCDF","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654001263","title":"YD Bio Launches Cancer Testing Pilot with Numia Health in Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=2654001263","media":"Reuters","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654001263?lang=en_us&edition=fundamental","pubTime":"2026-07-28 20:01","pubTimestamp":1785240074,"startTime":"0","endTime":"0","summary":"YD Bio launches cancer testing pilot with Numia Health in CanadaYD Bio launched a six-month pilot with Numia Health to build a cross-border workflow for physician-ordered blood-based cancer testing in","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nNDL1r5N7l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","IE00BN0W2T93.GBP","SG9999014013.SGD","SG9999014005.SGD","IE00BKPKM429.USD","BCDF","BK4112","YDES","IE00BN0W2V16.EUR","NDAQ","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","LU2095319765.USD","LU2210150020.SGD","LU0314104364.USD","SG9999014039.USD","BK4588","IE00B64PRP62.GBP","LU2210149790.SGD","SG9999014021.USD","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648502274","title":"YD Bio Wins Rhode Island, Pennsylvania Lab Licenses, Expanding U.S. Footprint to 46 States","url":"https://stock-news.laohu8.com/highlight/detail?id=2648502274","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648502274?lang=en_us&edition=fundamental","pubTime":"2026-07-02 20:01","pubTimestamp":1782993679,"startTime":"0","endTime":"0","summary":"YD Bio wins Rhode Island, Pennsylvania lab licenses, expanding U.S. footprint to 46 statesYD Bio affiliate EG BioMed US secured out-of-state clinical laboratory licenses in Rhode Island, Pennsylvania ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nNDLbGf6BG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","LU2210150020.SGD","LU2095319765.USD","IE00BN0W2T93.GBP","SG9999014005.SGD","SG9999014039.USD","BK4112","BK4588","BK4585","SG9999014013.SGD","IE00BKPKM429.USD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","BK4139","LU2210149790.SGD","SG9999014021.USD","LU0314104364.USD","YDES","NDAQ","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640860481","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 02:48 PM","url":"https://stock-news.laohu8.com/highlight/detail?id=2640860481","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640860481?lang=en_us&edition=fundamental","pubTime":"2026-06-04 02:48","pubTimestamp":1780512481,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 02:48 PM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nAQN2M1ZOW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","YDES"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632662735","title":"Yd Bio Limited Reports Full Year 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2632662735","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632662735?lang=en_us&edition=fundamental","pubTime":"2026-05-01 06:00","pubTimestamp":1777586400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nTUA3FLTRZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["YDES","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632662168","title":"YD Bio FY25 net loss widens to $8.3 million; revenue rises 17% to $596,817","url":"https://stock-news.laohu8.com/highlight/detail?id=2632662168","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632662168?lang=en_us&edition=fundamental","pubTime":"2026-05-01 05:46","pubTimestamp":1777585560,"startTime":"0","endTime":"0","summary":"YD Bio posted a net loss of USD 8.31 million for fiscal 2025, widening from a net loss of USD 1.41 million a year earlier.Operating loss widened to USD 5.27 million from USD 1.46 million.Cash and cash equivalents climbed to USD 6 million from USD 3.1 million, following a PIPE financing that secured USD 13.2 million in gross proceeds.For 2026, YD Bio forecast USD 2.4 million to USD 2.7 million of operating cash needs and USD 9 million to USD 10 million of capital expenditures, primarily tied to real estate and production-facility investment.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. YD Bio Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL1LNZbv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YDES","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625965031","title":"YD Bio Ltd trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2625965031","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625965031?lang=en_us&edition=fundamental","pubTime":"2026-04-08 04:01","pubTimestamp":1775592082,"startTime":"0","endTime":"0","summary":"15:56 EDT YD Bio (YDES)Ltd trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, market-moving br...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/yd-bio-ltd-trading-halted-volatility-trading-pause-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/yd-bio-ltd-trading-halted-volatility-trading-pause-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","YDES"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625965556","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 03:56 PM","url":"https://stock-news.laohu8.com/highlight/detail?id=2625965556","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625965556?lang=en_us&edition=fundamental","pubTime":"2026-04-08 03:56","pubTimestamp":1775591787,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 03:56 PM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nAQN2LTMJS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YDES","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624850582","title":"YD Bio files Form 3 as director Kochi Chang reports no beneficial ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2624850582","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624850582?lang=en_us&edition=fundamental","pubTime":"2026-04-02 19:27","pubTimestamp":1775129256,"startTime":"0","endTime":"0","summary":"YD Bio reported Director Kochi Chang in an initial Form 3 filing dated March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. YD Bio Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 02, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nNDL1hg9JX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YDES","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623324342","title":"YD Bio files Form 3; director Jerry Yin-Chia Lee reports no securities owned","url":"https://stock-news.laohu8.com/highlight/detail?id=2623324342","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623324342?lang=en_us&edition=fundamental","pubTime":"2026-03-31 05:30","pubTimestamp":1774906252,"startTime":"0","endTime":"0","summary":"YD Bio filed an initial Form 3 naming Jerry Yin-Chia Lee as a director, dated March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. YD Bio Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 30, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL30KLrd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YDES","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622870739","title":"YD Bio files initial beneficial ownership statement; Chief Medical Officer and director Zhang Bo-Xiang reports 31,141 ordinary shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2622870739","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622870739?lang=en_us&edition=fundamental","pubTime":"2026-03-28 04:05","pubTimestamp":1774641937,"startTime":"0","endTime":"0","summary":"YD Bio files initial beneficial ownership statement; Chief Medical Officer and director Zhang Bo-Xiang reports 31,141 ordinary shares. YD Bio reported that director and Chief Medical Officer Bo-Xiang Zhang beneficially owns 31,141 ordinary shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. YD Bio Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 27, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDL3Rfgsq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","YDES"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":26,"code":"91000000","status":"200"}]}}